Lab workflows are constantly evolving to handle higher throughput demands, increased efficiency, and more complex tasks. For some, that means allowing automation to play a bigger role in the lab.
Amid an uncertain market with continued pressure to produce positive testing results and a steady downturn in venture capital funding, life sciences startups are being asked to do more with less.
The lab automation market is expected to surpass $8.36 billion globally in 2025 and reach $14.78 billion by 2034. Pharmaceutical and biotech companies are making huge investments in lab automation ...
WALTHAM, Mass. & WADDINXVEEN, The Netherlands--(BUSINESS WIRE)--Genie Life Sciences, a greater Boston-based biotech startup providing laboratory automation through software and robotics, announced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results